Quest Partners LLC acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,725 shares of the specialty pharmaceutical company’s stock, valued at approximately $150,000. Other institutional investors and hedge […]